Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis.

被引：0

作者：

van Herwaarden, Noortje ^{[1
]}

van der Maas, Aatke ^{[1
]}

Minten, Michiel ^{[1
]}

van den Hoogen, Frank H. J. ^{[2
,3
]}

van Vollenhoven, Ronald F. ^{[4
]}

Bijlsma, Johannes W. J. ^{[5
]}

van den Bemt, Bart ^{[1
]}

den Broeder, Alfons A. ^{[1
]}

机构：

[1] Sint Maartensklin, Nijmegen, Netherlands

[2] Sint Maartensklin, Rheumatol Ctr, Nijmegen, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands

[4] Karolinska Inst, Unit Clin Therapy Res ClinTrid, Stockholm, Sweden

[5] Univ Med Ctr Utrecht, Utrecht, Netherlands

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1843

引用

页码：S810 / S811

页数：2

共 50 条

[31] Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world
Yang, M.
Galebach, P. J.
Signorovitch, J. E.
Garg, V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 791 - 798
[32] Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial
Bouman, Chantal A. M.
van Herwaarden, Noortje
van den Hoogen, Frank H. J.
Fransen, Jaap
van Vollenhoven, Ronald F.
Bijlsma, Johannes W. J.
van der Maas, Aatke
den Broeder, Alfons A.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (10) : 1716 - 1722
[33] RANDOMIZED EFFICACY AND DISCONTINUATION STUDY OF ETANERCEPT VERSUS ADALIMUMAB (RED SEA): A PRAGMATIC, OPEN-LABEL, NON-INFERIORITY STUDY OF FIRST TNF INHIBITOR USE IN RHEUMATOID ARTHRITIS: 1-YEAR DATA
Jobanputra, Paresh
Maggs, Fiona
Deeming, Alison
Carruthers, David
Rankin, Elizabeth
Jordan, Alison
Faizal, Abdul
Goddard, Carolyn
Pugh, Mark
Bowman, Simon
Brailsford, Sue
Nightingale, Peter
RHEUMATOLOGY, 2012, 51 : 116 - 117
[34] A TELE-HEALTH FOLLOW-UP STRATEGY FOR TIGHT CONTROL OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: RESULTS OF THE NON-INFERIORITY RANDOMISED CONTROLLED TRAIL (THE TERA STUDY)
Thurah, A.
Steengaard-Pedersen, K.
Axelsen, M.
Fredberg, U.
Schougaard, L. M. V.
Hjollund, N. H. I.
Pfeiffer-Jensen, M.
Laurberg, T. B.
Lomborg, K.
Maribo, T.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 454 - 455
[35] Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial (vol 1, pg 145, 2019)
Verhoef, L. M.
Den Broeder, N.
Thurlings, R. M.
LANCET RHEUMATOLOGY, 2021, 3 (10): : E687 - E687
[36] The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Tanaka, Yoshiya
Smolen, Josef S.
Jones, Heather
Szumski, Annette
Marshall, Lisa
Emery, Paul
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[37] The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Yoshiya Tanaka
Josef S. Smolen
Heather Jones
Annette Szumski
Lisa Marshall
Paul Emery
Arthritis Research & Therapy, 21
[38] Adalimumab clinical trial safety in multiple indications and reduction in mortality in rheumatoid arthritis.
Burmester, G. R.
Mease, P. J.
Dijkmans, B. A. C.
Gordon, K. B.
Lovell, D. J.
Kent, J. D.
Pangan, A. L.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S232 - S232
[39] The effect of acupuncture on patients with rheumatoid arthritis.: A randomised placebo controlled crossover study.
David, J
Townsend, S
Sathananthan, R
Kriss, S
Doré, C
ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S316 - S316
[40] Comparing foot and hand cardiopulmonary resuscitation: a non-inferiority, crossover, randomised controlled simulation study
Lee, Kui Ja
Kim, Hee Eun
Park, Seung Min
Jo, You Hwan
Yang, Hae Chul
Kim, Yong Won
Lee, Dong Keon
Jang, Dong-Hyun
SIGNA VITAE, 2025, 21 (01) : 60 - 68

← 1 2 3 4 5 →